Scotia Capital’s Lam Research LRCX Stock Holding History

Scotia Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-100,000	Closed	-$794K	–	787
2015 Q4	$794K	Hold	100,000	–	–	0.02%	459
2015 Q3	$653K	Buy	+100,000	New	+$733K	0.01%	484

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scotia Capital's LRCX Position: Q2 2026 in Review

Scotia Capital increased its Lam Research (LRCX) stake by 2% in Q2 2026, buying an estimated $1.86M and bringing the position to 306,579 shares worth $133M. The position accounts for 0.5% of the portfolio, ranked #42.

Scotia Capital first reported a position in LRCX in Q3 2014 and has held it in 40 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Scotia Capital held 306,579 shares of Lam Research worth $133M as of Q2 2026.
Scotia Capital bought 6,123 Lam Research shares in Q2 2026, an estimated $1.86M.
Lam Research made up 0.5% of Scotia Capital's portfolio in Q2 2026, its #42 holding.
Scotia Capital first reported a position in Lam Research in Q3 2014 and has held it in 40 quarters since.
3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.